Hepatobiliary Malignancies

You have free access to this content

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States†

  1. Jessica A. Davila1,‡,*,
  2. Robert O. Morgan1,
  3. Peter A. Richardson1,
  4. Xianglin L. Du3,
  5. Katherine A. McGlynn4,
  6. Hashem B. El-Serag1,2

Article first published online: 23 FEB 2010

DOI: 10.1002/hep.23615

Issue

Hepatology

Hepatology

Volume 52, Issue 1, pages 132–141, July 2010

Additional Information

How to Cite

Davila, J. A., Morgan, R. O., Richardson, P. A., Du, X. L., McGlynn, K. A. and El-Serag, H. B. (2010), Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology, 52: 132–141. doi: 10.1002/hep.23615

Author Information

  1. 1

    Sections of Health Services Research, Houston Center for Quality of Care & Utilization Studies, Houston VA Medical Center and Baylor College of Medicine, Houston, TX

  2. 2

    Sections of Gastroenterology, Houston Center for Quality of Care & Utilization Studies, Houston VA Medical Center and Baylor College of Medicine, Houston, TX

  3. 3

    Department of Epidemiology, The University of Texas School of Public Health, Houston, TX

  4. 4

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, MD

  1. ‡

    fax: 713-748-7359

*The Michael E. DeBakey VA Medical Center, 2002 Holcombe Boulevard (152), Houston, TX 77030

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 23 JUN 2010
  2. Article first published online: 23 FEB 2010
  3. Manuscript Accepted: 1 FEB 2010
  4. Manuscript Received: 27 JUL 2009

Funded by

  • American Cancer Society. Grant Number: RSGPB-07-010-01-CPHPS
  • NCI. Grant Numbers: R01 125487, DK K24 04107
  • Houston VA Health Services Research and Development Center of Excellence. Grant Number: HFP90-020

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (131K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alain Braillon, Hepatocellular Carcinoma: Still in Search of Evidence-Based Care, Clinical Gastroenterology and Hepatology, 2012, 10, 2, 205

    CrossRef

  2. 2
    Zhi-yong Huang, Bin-yong Liang, Min Xiong, Da-qian Zhan, Shuang Wei, Guo-ping Wang, Yi-fa Chen, Xiao-ping Chen, Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in China, Annals of Surgical Oncology, 2012,

    CrossRef

  3. 3
    Valérie Bourcier, Maria Winnock, Mohand Ait Ahmed, Philippe Sogni, Elodie Pambrun, Isabelle Poizot-Martin, Cendrine Chaffaut, Sylvie Chevret, Jean-Claude Trinchet, Dominique Salmon, Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir), Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 3, 214

    CrossRef

  4. 4
    Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Felicity T. Enders, Terry M. Therneau, Lucinda Orsini, W. Ray Kim, Lewis R. Roberts, Reply, Clinical Gastroenterology and Hepatology, 2012, 10, 2, 205

    CrossRef

  5. 5
    E C Persson, S M Quraishi, T M Welzel, J D Carreon, G Gridley, B I Graubard, K A McGlynn, Risk of liver cancer among US male veterans with cirrhosis, 1969–1996, British Journal of Cancer, 2012,

    CrossRef

  6. 6
    Ju Dong Yang, W. Ray Kim, Surveillance for Hepatocellular Carcinoma in Patients With Cirrhosis, Clinical Gastroenterology and Hepatology, 2012, 10, 1, 16

    CrossRef

  7. 7
    Valentina Santi, Daniela Buccione, Antonio Di Micoli, Gianluca Fatti, Marta Frigerio, Fabio Farinati, Paolo Del Poggio, Gianludovico Rapaccini, Maria Anna Di Nolfo, Luisa Benvegnù, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Maria Chiaramonte, Mauro Bernardi, Franco Trevisani, The changing scenario of hepatocellular carcinoma over the last two decades in Italy, Journal of Hepatology, 2012, 56, 2, 397

    CrossRef

  8. 8
    Amit G. Singal, Adam Yopp, Celette S. Skinner, Milton Packer, William M. Lee, Jasmin A. Tiro, Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review, Journal of General Internal Medicine, 2012,

    CrossRef

  9. 9
    C. Rajasekharan, V. Ganga, A Rare Cause for Acute Cor Pulmonale, Case Reports in Gastroenterology, 2011, 5, 2, 330

    CrossRef

  10. 10
    Florian Hucke, Wolfgang Sieghart, Maximilian Schöniger-Hekele, Markus Peck-Radosavljevic, Christian Müller, Clinical characteristics of patients with hepatocellular carcinoma in Austria – is there a need for a structured screening program?, Wiener klinische Wochenschrift, 2011, 123, 17-18, 542

    CrossRef

  11. 11
    Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Roongruedee Chaiteerakij, Felicity T. Enders, Terry M. Therneau, Lucinda Orsini, W. Ray Kim, Lewis R. Roberts, Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance, Clinical Gastroenterology and Hepatology, 2011, 9, 7, 617

    CrossRef

  12. 12
    Hashem B. El-Serag, Hepatocellular Carcinoma, New England Journal of Medicine, 2011, 365, 12, 1118

    CrossRef

  13. 13
    Vilas Patwardhan, Sonali Paul, Kathleen E. Corey, Sameer M. Mazhar, James M. Richter, Michael Thiim, Raymond T. Chung, Hepatocellular Carcinoma Screening Rates Vary by Etiology of Cirrhosis and Involvement of Gastrointestinal Sub-specialists, Digestive Diseases and Sciences, 2011, 56, 11, 3316

    CrossRef

  14. 14
    Jeong Min Lee, Franco Trevisani, Valerie Vilgrain, Christoph Wald, Imaging diagnosis and staging of hepatocellular carcinoma, Liver Transplantation, 2011, 17, S2
    Direct Link:
  15. 15
    Howard C. Masuoka, Charles B. Rosen, Liver Transplantation for Hepatocellular Carcinoma: Expanding Frontiers and Building Bridges, Clinics in Liver Disease, 2011, 15, 2, 385

    CrossRef

  16. 16
    Jean-Claude Trinchet, Surveillance for hepatocellular carcinoma in cirrhotic patients: From official recommendations to the real life, Journal of Hepatology, 2011, 54, 6, 1310

    CrossRef

  17. 17
    Angelo Sangiovanni, Massimo Colombo, Surveillance for hepatocellular carcinoma: A standard of care, not a clinical option, Hepatology, 2011, 54, 6
    Direct Link:
  18. 18
    Augusto Villanueva, Josep M. Llovet, Targeted Therapies for Hepatocellular Carcinoma, Gastroenterology, 2011, 140, 5, 1410

    CrossRef

  19. 19
    Matthew P. Landman, Irene D. Feurer, C. Wright Pinson, Derek E. Moore, Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?, HPB, 2011, 13, 11
    Direct Link:
View Full Article with Supporting Information (HTML) Get PDF (131K)